Found: 15
Select item for more details and to access through your institution.
Radiotherapy with a Radiolabeled Somatostatin Analogue, [<sup>111</sup>In-DTPA- d-Phe<sup>1</sup>]-Octreotide.
- Published in:
- Annals of the New York Academy of Sciences, 1994, v. 733, n. 1, p. 496, doi. 10.1111/j.1749-6632.1994.tb17300.x
- By:
- Publication type:
- Article
Lung clearance of intratracheally instilled <sup>99m</sup>Tc-tobramycin using pulmonary surfactant as vehicle.
- Published in:
- British Journal of Pharmacology, 1999, v. 126, n. 5, p. 1091, doi. 10.1038/sj.bjp.0702405
- By:
- Publication type:
- Article
Clinical Validation of Fully Automated Computation of Ejection Fraction from Gated Equilibrium Blood-Pool Scintigrams.
- Published in:
- Journal of Nuclear Medicine, 1983, v. 24, n. 12, p. 1099
- By:
- Publication type:
- Article
Comparison of three radiolabelled peptide analogues for CCK-2 receptor scintigraphy in medullary thyroid carcinoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2009, v. 36, n. 8, p. 1265, doi. 10.1007/s00259-009-1098-9
- By:
- Publication type:
- Article
Comparison of [<sup>177</sup>Lu-DOTA<sup>0</sup>,Tyr<sup>3</sup>]octreotate and [<sup>177</sup>Lu-DOTA<sup>0</sup>,Tyr<sup>3</sup>]octreotide: which peptide is preferable for PRRT?
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2006, v. 33, n. 11, p. 1346, doi. 10.1007/s00259-006-0172-9
- By:
- Publication type:
- Article
Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [[sup 177] Lu-DOTA[sup 0] ,Tyr[sup 3] ]octreotate.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2003, v. 30, n. 3, p. 417, doi. 10.1007/s00259-002-1050-8
- By:
- Publication type:
- Article
Peptide Receptor Radionuclide Therapy for Non--Radioiodine-Avid Differentiated Thyroid Carcinoma.
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 2, p. 107S
- By:
- Publication type:
- Article
Long-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with <sup>90</sup>Y-DOTA<sup>0</sup>,Tyr³-Octreotide and <sup>177</sup>Lu-DOTA<sup>0</sup>, Tyr³-Octreotate.
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 2, p. 83S
- By:
- Publication type:
- Article
Tumor Response After [<sup>90</sup>Y-DOTA<sup>0</sup>,Tyr³]- Octreotide Radionuclide Therapy in a Transplantable Rat Tumor Model Is Dependent on Tumor Size.
- Published in:
- Journal of Nuclear Medicine, 2001, v. 42, n. 12, p. 1841
- By:
- Publication type:
- Article
Radiation Dosimetry for Indium-111-Pentetreotide.
- Published in:
- Journal of Nuclear Medicine, 1997, v. 38, n. 12, p. 1919
- By:
- Publication type:
- Article
Effect of Dose and Specffic Activity on Tissue Distribution of Indium-111-Pentetreotide in Rats.
- Published in:
- Journal of Nuclear Medicine, 1995, v. 36, n. 4, p. 623
- By:
- Publication type:
- Article
Hepatobiliary Handling of Iodine-125-Tyr³-Octreotide and Indium-111-DTPA-D-Phe¹ Octreotide by Isolated Perfused Rat Liver.
- Published in:
- Journal of Nuclear Medicine, 1993, v. 34, n. 11, p. 2025
- By:
- Publication type:
- Article
Octreotide Scintigraphy for the Detection of Paragangliomas.
- Published in:
- Journal of Nuclear Medicine, 1993, v. 34, n. 6, p. 873
- By:
- Publication type:
- Article
Somatostatin Receptor Scintigraphy with Indium-111-DTPA-D-Phe-1-Octreotide in Man: Metabolism, Dosimetry and Comparison with Iodine-123-Tyr-3-Octreotide.
- Published in:
- Journal of Nuclear Medicine, 1992, v. 33, n. 5, p. 652
- By:
- Publication type:
- Article
The Selenium-75-Homocholic Acid Taurine Test Reevaluated: Combined Measurement of Fecal Selenium-75 Activity and 3α-Hydroxy Bile Acids in 211 Patients.
- Published in:
- Journal of Nuclear Medicine, 1991, v. 32, n. 6, p. 1219
- By:
- Publication type:
- Article